Latin-American multicentric study with orlistat in overweight or obese patients with type 2 diabetes

被引：0
|
作者：
Halpern, A
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A437 / A437
页数：1
相关论文
共 50 条
  • [31] Orlistat promotes weight loss and improves glycaemic control in overweight patients with type 2 diabetes
    Hanefeld, M
    Platon, J
    Sachse, G
    DIABETOLOGIA, 2001, 44 : A231 - A231
  • [32] Effect of orlistat on weight loss and glycemic control in overweight Chinese patients with type 2 diabetes
    Shi, YF
    Zhu, JR
    DIABETES, 2001, 50 : A101 - A102
  • [33] Orlistat reduces both anthropometric and analytic parameters in obese patients or patients with overweight type II
    Lobon Hernandez, Ja
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S171 - S171
  • [34] Quality of life of Latin-American individuals with type 2 diabetes mellitus: A systematic review
    Sanchez de la Cruz, Juan Pablo
    Gonzalez Morales, Diana Laura
    Beatriz Gonzalez-Castro, Thelma
    Alfonso Tovilla-Zarate, Carlos
    Esther Juarez-Rojop, Isela
    Lopez-Narvaez, Lilia
    Hernandez-Diaz, Yazmin
    Luis Ble-Castillo, Jorge
    Perez-Hernandez, Nonancit
    Manuel Rodriguez-Perez, Jose
    PRIMARY CARE DIABETES, 2020, 14 (04) : 317 - 334
  • [35] HbA1c reduction at week 12 predicts treatment outcome with Orlistat in patients with Type 2 diabetes who are overweight/obese
    Hollander, P
    Ruof, J
    DIABETOLOGIA, 2002, 45 : A220 - A220
  • [36] Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
    Scheen, Andre J.
    Finer, Nick
    Hollander, Priscilla
    Jensen, Michael D.
    Van Gaal, Luc F.
    LANCET, 2006, 368 (9548): : 1660 - 1672
  • [37] Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes (vol 25, pg 1033, 2002)
    Kelley, DE
    Bray, GA
    Pi-Sunyer, FX
    Klein, S
    Hill, J
    Miles, J
    Hollander, P
    DIABETES CARE, 2002, 25 (08) : 1495 - 1495
  • [38] Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes (vol 24, pg 1033, 2002)
    Kelley, DE
    Bray, GA
    Pi-Sunyer, FX
    Klein, S
    Hill, J
    Miles, J
    Hollander, P
    DIABETES CARE, 2003, 26 (03) : 971 - 971
  • [39] Orlistat (xenical®) reduces cardiovascular disease risk factors in obese patients with type 2 diabetes
    Hollander, P
    Lucas, C
    Segal, KR
    DIABETOLOGIA, 1998, 41 : A126 - A126
  • [40] Effects of weight reduction with orlistat on cardiovascular risk in obese hyertensive patients with type 2 diabetes
    Uehara, MH
    Peres, RB
    Ferreira, SRG
    Zanella, MT
    HYPERTENSION, 2001, 37 (03) : 1042 - 1042
12345